• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Protein kinase C alpha and tumorigenesis of the endocrine gland.

作者信息

Prévostel C, Martin A, Alvaro V, Jaffiol C, Joubert D

机构信息

INSERM U401, Montpellier, France.

出版信息

Horm Res. 1997;47(4-6):140-4. doi: 10.1159/000185457.

DOI:10.1159/000185457
PMID:9167945
Abstract

A point mutation in the protein kinase C alpha (PKC alpha) gene has been discovered in a subpopulation of human pituitary tumors characterized by their invasive phenotype. Here we show that: (1) thyroid tumors can express the PKC alpha mutation detected in a subpopulation of follicular adenomas and carcinomas, and (2) mutated PKC alpha has modified enzymatic properties as compared to wild-type PKC alpha. It has lost its capacity to phosphorylate the S17R substrate and exhibits a higher sensitivity to degradation as compared to wild-type PKC alpha. In conclusion, the presence of the PKC alpha mutant in tumors other than pituitary tumors and the observation that the presence of the point mutation induces changes in PKC alpha properties suggest the involvement of this mutant in tumorigenesis.

摘要

相似文献

1
Protein kinase C alpha and tumorigenesis of the endocrine gland.
Horm Res. 1997;47(4-6):140-4. doi: 10.1159/000185457.
2
The natural protein kinase C alpha mutant is present in human thyroid neoplasms.天然蛋白激酶Cα突变体存在于人类甲状腺肿瘤中。
Oncogene. 1995 Aug 17;11(4):669-74.
3
Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon.
J Clin Endocrinol Metab. 2002 May;87(5):2150-9. doi: 10.1210/jcem.87.5.8441.
4
Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.人甲状腺癌细胞系和原发性甲状腺癌中细胞周期蛋白依赖性激酶抑制剂p15INK4b和p16INK4a的遗传和表观遗传改变。
Cancer. 1998 Nov 15;83(10):2185-93.
5
Protein kinase C activity in human thyroid carcinoma and adenoma.人类甲状腺癌和腺瘤中的蛋白激酶C活性
Cancer. 1992 Dec 15;70(12):2918-22. doi: 10.1002/1097-0142(19921215)70:12<2918::aid-cncr2820701231>3.0.co;2-5.
6
The PKCalpha-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals.在垂体和甲状腺肿瘤中发现的PKCalpha - D294G突变体无法转导细胞外信号。
Cancer Res. 2005 Jun 1;65(11):4520-4. doi: 10.1158/0008-5472.CAN-04-4506.
7
Analysis of a protein kinase C-alpha mutation in human pituitary tumours.人类垂体肿瘤中蛋白激酶C-α突变的分析
J Endocrinol. 1997 Apr;153(1):131-7. doi: 10.1677/joe.0.1530131.
8
p53 mutations in all stages of thyroid carcinomas.甲状腺癌各阶段中的p53突变
J Clin Endocrinol Metab. 1993 Oct;77(4):1054-8. doi: 10.1210/jcem.77.4.8408453.
9
Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C.
J Clin Endocrinol Metab. 1993 Nov;77(5):1125-9. doi: 10.1210/jcem.77.5.8077302.
10
Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in thyroid neoplasia.甲状腺肿瘤中编码G11和Gqα亚基的基因无激活突变。
J Clin Endocrinol Metab. 1998 Feb;83(2):554-9. doi: 10.1210/jcem.83.2.4536.

引用本文的文献

1
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases.蛋白激酶作为治疗靶点的最新研究进展——第一部分:蛋白激酶 C 的激活及其在癌症和心血管疾病中的作用。
Int J Mol Sci. 2023 Dec 18;24(24):17600. doi: 10.3390/ijms242417600.
2
Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer.蛋白激酶C(PKC)同工酶作为癌症的诊断和预后生物标志物及治疗靶点
Cancers (Basel). 2022 Nov 3;14(21):5425. doi: 10.3390/cancers14215425.
3
PKC-mediated phosphorylation of nuclear lamins at a single serine residue regulates interphase nuclear size in and mammalian cells.
蛋白激酶C介导的单个丝氨酸残基处核纤层蛋白的磷酸化作用调节果蝇和哺乳动物细胞的间期核大小。
Mol Biol Cell. 2017 May 15;28(10):1389-1399. doi: 10.1091/mbc.E16-11-0786. Epub 2017 Mar 29.
4
Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.癌症相关的蛋白激酶C突变揭示了该激酶作为肿瘤抑制因子的作用。
Cell. 2015 Jan 29;160(3):489-502. doi: 10.1016/j.cell.2015.01.001. Epub 2015 Jan 22.
5
Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.蛋白激酶 C(PKC)作为慢性淋巴细胞白血病的药物靶点。
Med Oncol. 2013 Dec;30(4):757. doi: 10.1007/s12032-013-0757-7. Epub 2013 Oct 31.